Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 06, 2022 Filed Apr 8, 2022 21:09 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantPerformance Share Units · Derivative | 510.5353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023880 · doc4.xml · derivative · entry 6 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,054.8905 Underlying: Common Shares · 510.5353 shares Expires 2024-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:09 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantRestricted Share Units · Derivative | 71.0115 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023880 · doc4.xml · derivative · entry 5 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,796.7958 Underlying: Common Shares · 71.0115 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:09 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantRestricted Share Units · Derivative | 58.4665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023880 · doc4.xml · derivative · entry 4 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,419.4061 Underlying: Common Shares · 58.4665 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 103.2074 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 11 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,336.2074 Underlying: Common Shares · 103.2074 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 159.1804 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 10 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,484.2379 Underlying: Common Shares · 159.1804 shares Expires 2024-02-19 F10 · derivative.exercise_price: The share reported represent an award of performance base restricted share units (the "2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning on January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 47.7256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 9 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,242.1399 Underlying: Common Shares · 47.7256 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 52.2682 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 8 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,741.093 Underlying: Common Shares · 52.2682 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 247.7258 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 7 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,209.9782 Underlying: Common Shares · 247.7258 shares Expires 2025-02-21 F7 · derivative.exercise_price: The share reported represent an award of performance base restricted share units (the "2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 510.3011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 6 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,051.0187 Underlying: Common Shares · 510.3011 shares Expires 2024-02-22 F5 · derivative.exercise_price: The share reported represent an award of performance base restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2024, which is the fifth anniversary of the grant date. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 26.0707 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 5 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,863.5781 Underlying: Common Shares · 26.0707 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:05 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 27.7706 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023871 · doc4.xml · derivative · entry 4 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050.2964 Underlying: Common Shares · 27.7706 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F3 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 00:13 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantRestricted Share Units · Derivative | 8,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-013790 · doc4.xml · derivative · entry 14 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,657 Underlying: Common Shares · 8,657 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUS") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 00:13 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
GrantCommon Shares | 2,308 | $56.05 | $129,363.40 |
DisclosureSEC source: 0001209191-22-013790 · doc4.xml · nonDerivative · entry 3 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,129.0663 F2 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F3 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 13 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 00:13 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
SaleCommon Shares | 5,000 | $56.45 | $282,250.00 |
DisclosureSEC source: 0001209191-22-013790 · doc4.xml · nonDerivative · entry 2 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,821.0663 F1 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from $56.40 to $56.53 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:16 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014304 · doc4.xml · derivative · entry 14 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 Underlying: Common Shares · 11,875 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F12 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:16 UTC |
Housman JeffreySee Remarks
|
GrantCommon Shares | 3,166 | $56.05 | $177,454.30 |
DisclosureSEC source: 0001209191-22-014304 · doc4.xml · nonDerivative · entry 1 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,970.2232 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchases price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 12 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 18:19 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 18,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014314 · doc4.xml · derivative · entry 16 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,990 Underlying: Common Shares · 18,990 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F15 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice president and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F16 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F16 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 18:19 UTC |
Shear David ChanPresident, International
|
GrantCommon Shares | 4,895 | $56.05 | $274,364.75 |
DisclosureSEC source: 0001209191-22-014314 · doc4.xml · nonDerivative · entry 1 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,267.4645 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 15 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 9,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014307 · doc4.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,144 Underlying: Common Shares · 9,144 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F8 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:17 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantCommon Shares | 2,438 | $56.05 | $136,649.90 |
DisclosureSEC source: 0001209191-22-014307 · doc4.xml · nonDerivative · entry 1 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,860.3239 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 8 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:20 UTC |
Cil Jose E.Chief Executive Officer
|
GrantRestricted Share Units · Derivative | 45,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014316 · doc4.xml · derivative · entry 22 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,404 Underlying: Common Shares · 45,404 shares Expires not disclosed F12 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F22 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F23 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F23 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:20 UTC |
Cil Jose E.Chief Executive Officer
|
GrantCommon Shares | 12,107 | $56.05 | $678,597.35 |
DisclosureSEC source: 0001209191-22-014316 · doc4.xml · nonDerivative · entry 1 Cil Jose E. · CIK 0001552282 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,006.243 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 22 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:13 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 17,091 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014297 · doc4.xml · derivative · entry 18 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,091 Underlying: Common Shares · 17,091 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F14 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of her 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, she will forfeit all of the 2022 RSUs that have not yet vested. F15 · derivative.exercise_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F15 · derivative.expiration_date: The restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:13 UTC |
Granat JillSee Remarks
|
GrantCommon Shares | 4,557 | $56.05 | $255,419.85 |
DisclosureSEC source: 0001209191-22-014297 · doc4.xml · nonDerivative · entry 1 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,727.9136 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of her investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of her 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 14 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:18 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 7,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014310 · doc4.xml · derivative · entry 12 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,235 Underlying: Common Shares · 7,235 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F12 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of her 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of her gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2 for senior vice presidents. If the Reporting Person sells any of the Investment Shares, she will forfeit all of the 2022 RSUs that have not vested. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 2025. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:18 UTC |
Friesner JacquelineSee Remarks
|
GrantCommon Shares | 2,170 | $56.05 | $121,628.50 |
DisclosureSEC source: 0001209191-22-014310 · doc4.xml · nonDerivative · entry 1 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,595.9982 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of her investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of her 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 12 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:14 UTC |
Kobza JoshuaCOO
|
GrantRestricted Share Units · Derivative | 30,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014301 · doc4.xml · derivative · entry 14 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,605 Underlying: Common Shares · 30,605 shares Expires not disclosed F11 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F15 · shares: The issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F16 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F16 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:14 UTC |
Kobza JoshuaCOO
|
GrantCommon Shares | 8,161 | $56.05 | $457,424.05 |
DisclosureSEC source: 0001209191-22-014301 · doc4.xml · nonDerivative · entry 1 Kobza Joshua · CIK 0001574771 · COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,063.1156 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 15 below pursuant to the Issuer's 20210 Bonus Swap Program is calculated based on, the last sale price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:15 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 13,912 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014303 · doc4.xml · derivative · entry 12 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,912 Underlying: Common Shares · 13,912 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F11 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:15 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantCommon Shares | 3,683 | $56.05 | $206,432.15 |
DisclosureSEC source: 0001209191-22-014303 · doc4.xml · nonDerivative · entry 1 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,210.816 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 11 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:18 UTC | GrantRestricted Share Units · Derivative | 15,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014311 · doc4.xml · derivative · entry 15 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,816 Underlying: Common Shares · 15,816 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · shares: The Issuer granted the 2022 restricted share units ("2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $56.05 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
|
| February 25, 2022 Filed Mar 1, 2022 23:18 UTC | GrantCommon Shares | 4,217 | $56.05 | $236,362.85 |
DisclosureSEC source: 0001209191-22-014311 · doc4.xml · nonDerivative · entry 1 Dunnigan Matthew · CIK 0001728874 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,449.1545 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Omnibus Incentive Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of $56.05 per share ("Investment Shares"). F2 · price: Pursuant to the Issuer's 2014 Omnibus Incentive Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 13 below pursuant to the Issuer's 2021 Bonus Swap Program is the last sales price of a common share of the Issuer on the New York Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
|
| February 25, 2022 Filed Mar 1, 2022 23:14 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 11,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014298 · doc4.xml · derivative · entry 11 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,233 Underlying: Common Shares · 11,233 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F11 · shares: The Issuer granted the 2022 restricted share units (2022 RSUs") to the Reporting Person pursuant to the Issuer's 2021 Bonus Swap Program under its 2014 Plan. The Reporting Person elected to use 50% of his 2021 net bonus to purchase Investment Shares and received a matching grant of 2022 RSUs in an amount equal to 50% of his gross bonus, multiplied by a multiple based on the Reporting Person's position level with the Issuer ("RSU Multiplier"), and divided by the purchase price of $55.91 per share. The RSU Multiplier was 2.25 for executive vice presidents and above. If the Reporting Person sells any of the Investment Shares, he will forfeit all of the 2022 RSUs that have not yet vested. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:14 UTC |
Fulton DuncanChief Corporate Officer
|
GrantCommon Shares | 2,496 | $55.91 | $139,551.36 |
DisclosureSEC source: 0001209191-22-014298 · doc4.xml · nonDerivative · entry 1 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,777.5743 F1 · shares: The shares reported represent common shares purchased from the Issuer by the Reporting Person upon exercise of his investment rights pursuant to the Issuer's 2021 Bonus Swap Program under its Amended and Restated 2014 Omnibus Incentive Plan ("2014 Plan"). The Reporting Person elected to use 50% of his 2021 net bonus to purchase common shares at a purchase price of CAD $71.74 per share. The purchase price was converted into its U.S. dollar equivalent using the Bank of Canada daily exchange rate on February 24, 2022. F2 · price: Pursuant to the Issuer's 2014 Plan, the purchase price of the Investment Shares is, and the number of matching restricted share units described in footnote 11 below pursuant to the Issuer's 2021 Bonus Swap Program is calculated based on, the last sales price of a common share of the Issuer on the Toronto Stock Exchange on the trading day immediately preceding the grant date, in this case February 24, 2022. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 23:12 UTC |
SWEENEY THECLADirector
|
GrantOption (Right to Buy) · Derivative | 17,841 | $0.00 Strike: $56.28 | $0.00 |
DisclosureSEC source: 0001209191-22-014295 · doc4.xml · derivative · entry 2 SWEENEY THECLA · CIK 0001901882 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,841 Underlying: Common Shares · 17,841 shares Expires 2032-01-01 F1 · derivative.exercise_price: The options were issued with an exercise price of CAD$71.74. The reported exercise price represents the U.S. dollar equivalent at the time of issuance. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:13 UTC |
Siddiqui Sami A.Brand Pres., Popeyes, Americas
|
SaleCommon Shares | 14,600 | $55.00 | $803,000.00 |
DisclosureSEC source: 0001209191-22-013790 · doc4.xml · nonDerivative · entry 1 Siddiqui Sami A. · CIK 0001829353 · Brand Pres., Popeyes, Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,821.0663 Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 309.7941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 16 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,650.1755 Underlying: Common Shares · 309.7941 shares Expires 2024-02-19 F14 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 74.2211 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 15 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,301.5614 Underlying: Common Shares · 74.2211 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 101.7234 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 14 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,377.6695 Underlying: Common Shares · 101.7234 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 31, 2023. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 186.5711 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 13 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,867.7979 Underlying: Common Shares · 186.5711 shares Expires 2025-02-21 F11 · derivative.exercise_price: The share reported represent an award of performance based restricted share units (the "2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 241.0767 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 12 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,964.2063 Underlying: Common Shares · 241.0767 shares Expires 2025-02-21 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2025, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 58.167 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 11 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,505.9237 Underlying: Common Shares · 58.167 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F9 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantPerformance Share Units · Derivative | 496.601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 9 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,544.3551 Underlying: Common Shares · 496.601 shares Expires 2024-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance base restricted share units (the "2019 PBRSUs") granted to the Reporting Person. The 2019 PBRSUs will have a performance period ending December 31, 2021 and to the extent earned will vest on February 21, 2024, which is the fifth anniversary of the grant date. The number of common shares that will be earned at the end of the performance period is subject to decrease based on the results of the performance condition. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 84.0547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 8 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,401.4375 Underlying: Common Shares · 84.0547 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F7 · derivative.exercise_date: These restricted share units vest on December 31, 2023. F7 · derivative.expiration_date: These restricted share units vest on December 31, 2023. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantRestricted Share Units · Derivative | 80.0601 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · derivative · entry 7 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,954.6486 Underlying: Common Shares · 80.0601 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2022. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2022. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
SaleCommon Shares | 9,036.9232 | $58.62 | $529,744.44 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · nonDerivative · entry 2 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,372.4645 F2 · shares: Represents shares sold to cover withholding tax obligations on the settlement of the reported vesting of the Reporting Person's performance based restricted share units. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 17:49 UTC |
Shear David ChanPresident, International
|
GrantCommon Shares | 169.0287 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002516 · doc4.xml · nonDerivative · entry 1 Shear David Chan · CIK 0001842463 · President, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,409.3878 F1 · shares: Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:47 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 135.3191 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002513 · doc4.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,135.3191 Underlying: Common Shares · 135.3191 shares Expires 2024-12-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-2 PBRSUs") granted to the Reporting Person. The 2021-2 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on December 15, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:47 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantRestricted Share Units · Derivative | 135.3191 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002513 · doc4.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,135.3191 Underlying: Common Shares · 135.3191 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F6 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. F6 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2022, December 15, 2023 and December 15, 2024. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 22:47 UTC |
CURTIS THOMAS BENJAMINSee Remarks
|
GrantPerformance Share Units · Derivative | 136.4768 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002513 · doc4.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,264.8061 Underlying: Common Shares · 136.4768 shares Expires 2024-09-01 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2021-1 PBRSUs") granted to the Reporting Person. The 2021-1 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on September 1, 2024, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.